about
The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Advances in HIV microbicide developmentCD169-dependent cell-associated HIV-1 transmission: a driver of virus disseminationOrigin of the transmitted virus in HIV infection: infected cells versus cell-free virusSemen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaquesInfection of female primary lower genital tract epithelial cells after natural pseudotyping of HIV-1: possible implications for sexual transmission of HIV-1.Mucosal transmission of human immunodeficiency virusTranscytosis of HIV-1 through vaginal epithelial cells is dependent on trafficking to the endocytic recycling pathway.The structure of the human vaginal stratum corneum and its role in immune defenseOral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells.HIV-1 transmission biology: selection and characteristics of infecting viruses.Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.Rectal microbicide development.Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo.Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition.Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsStrategies for preventing mucosal cell-associated HIV transmission.Characteristics and quantities of HIV host cells in human genital tract secretionsModeling mucosal cell-associated HIV type 1 transmission in vitro.Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia.The rise and fall of HIV in high-prevalence countries: a challenge for mathematical modeling.Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity.Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral TherapyIn vitro activities of candidate microbicides against cell-associated HIVAssociations between virologic and immunologic dynamics in blood and in the male genital tract.MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epitheliaTransmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.HIV-1 vaginal transmission: cell-free or cell-associated virus?Visualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study.Pathways of cell-cell transmission of HTLV-1Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary.Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cellsBroadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex VivoM48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding.
P2860
Q26753146-40D9A665-665B-4FEA-A9CA-1F6437B6A9B4Q26852858-D77565FE-21E3-4320-B7CE-BF28FF5A53E2Q27008186-F662976A-0708-476C-A133-51377BCB31AEQ27021279-278C8FE6-FB9A-4566-9D6E-E89B3A0B4894Q27331721-B05FBA04-ED97-4E4C-817E-9455B97BCB37Q30364549-39E84F13-0A3A-4CBE-9715-F6A8BAE3440DQ30412036-625BB1A8-7B54-485A-987B-259B7C29D90BQ33618602-290C2574-15E7-4361-889E-E6B5B3C49184Q33624947-787BBB59-4BA3-489D-9B79-1A2537684496Q33654841-997DEE6C-B217-4133-BAEC-2AF01D14E256Q33954381-CEFEF9C3-9406-489E-A622-5583A9243D0DQ34158525-E28298F3-6002-4B92-A08C-E595DF026588Q34206171-92722D67-4674-4E40-B291-A972022B077CQ34554611-EAF21E8D-B1D7-45B3-9C9C-5716A2F4AA40Q34575590-F2F89F2D-D6CD-4621-AE65-97F08BD60BD1Q34585676-D8067FCD-88AA-4276-8325-2E5765F670CCQ34598141-931D55F0-477D-4B21-BCA9-98D4662B1CB2Q34799419-ED635B68-212D-4DB5-A366-98A946BAD5C2Q34992670-1BA2BBDC-A7F8-4854-ABD9-3EB0E7B3AA7EQ35000010-267ACC8A-5212-4964-99DD-11246D4D2342Q35000052-E7712A82-2593-4876-9632-419792DCCF1EQ35000072-54C54A33-000B-4BAB-A8EB-C7ECB6F395B7Q35018140-A5C98861-657D-411D-956B-A352480178F3Q35068652-425E2928-2D73-42FF-BFC7-C48152D888EBQ35120060-05902654-9126-4E01-A4B5-76963D48209CQ35153213-D454AAAC-C78A-415A-9BE3-E522B4DF927DQ35641179-B3DFD206-FAFA-491F-AE6A-033B7158A885Q35689194-57B936FE-565D-43F7-AD70-45F85EDFFF97Q35689689-2A6EE5CE-4673-481A-BDC5-872F79705E2DQ35746218-006C4D4F-53D9-4FBE-89B8-D02F5D23A676Q35826167-0EDFEC28-0703-4C0F-9E7B-B1B7614F5C34Q35842299-CC7E9851-1CCE-44B9-8342-060886B8F66AQ35897398-B457097A-B3AA-4112-BB5B-AB5304DCFE15Q36242730-1C08CDF0-85E7-415A-B969-22B5C79A3BDDQ36343823-002B94E6-3554-4E09-94FB-C1145143898BQ36358993-1309E8EF-C737-4AE3-87FE-6E4C32BF4569Q36359817-B753D710-422D-429E-AA74-AE4A5F50668FQ36373244-E71263B7-29D8-43D7-B8CC-F20AB770A099Q36571900-281D3E85-9F92-44EE-949F-31B257207098Q36608485-635D1B07-AF90-4458-BB7F-09A434FA4F72
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting Trojan Horse leukocytes for HIV prevention.
@ast
Targeting Trojan Horse leukocytes for HIV prevention.
@en
Targeting Trojan Horse leukocytes for HIV prevention.
@nl
type
label
Targeting Trojan Horse leukocytes for HIV prevention.
@ast
Targeting Trojan Horse leukocytes for HIV prevention.
@en
Targeting Trojan Horse leukocytes for HIV prevention.
@nl
prefLabel
Targeting Trojan Horse leukocytes for HIV prevention.
@ast
Targeting Trojan Horse leukocytes for HIV prevention.
@en
Targeting Trojan Horse leukocytes for HIV prevention.
@nl
P2093
P2860
P50
P1433
P1476
Targeting Trojan Horse leukocytes for HIV prevention.
@en
P2093
Adam M Nadolski
Caitlin D Blaskewicz
Kenneth H Mayer
P2860
P304
P356
10.1097/QAD.0B013E32833424C8
P407
P577
2010-01-01T00:00:00Z